Insmed's DPP1 inhibitor Brinsupri (brensocatib) has been recommended by the CHMP for the treatment of patients aged 12 and ...

There are steps physicians can take to prepare their patients with pulmonary issues for the changing of the seasons.

Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...

Spotting ILDs may be challenging. Symptoms such as a dry cough, shortness of breath, and unexplained weight loss may go ...

EMA committee recommends approval of Insmed’s Brinsupri to treat non-cystic fibrosis bronchiectasis: Bridgewater, New Jersey Monday, October 20, 2025, 15:00 Hrs [IST] Insmed Inc ...

Climate change exacerbates health emergencies, affecting outcomes and healthcare access due to natural disasters like ...

RUH patients have taken to an inbox created by the Saskatchewan Union of Nurses to voice their frustrations. An ...

Winter places several predictable stresses on the respiratory system like cold, viruses and seasonal pollution but many of the harms can be reduced with regular, evidence-based exercise and breathing ...

Delhi’s air quality has plunged to hazardous levels, with AQI readings crossing 400 in several areas. Doctors warn that the toxic air is not only harming the lungs but also damaging the heart, ...

Illness severity, advanced age, and chronic liver disease were strong predictors of 30-day mortality among hospitalized ...

About 9 in 10 adults in the United States have not heard of cardiovascular-kidney-metabolic syndrome despite nearly 90% of ...

Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.